MedPath

Tomosynthesis in Screening Mammography

Not Applicable
Completed
Conditions
Breast Density >25%
Interventions
Procedure: Tomosynthesis
Procedure: 2D Mammogram
Registration Number
NCT01086241
Lead Sponsor
AHS Cancer Control Alberta
Brief Summary

Tomosynthesis is a new digital mammographic tool which can be performed at the same time as routine screening mammography. It creates CT-like slices through the breast, minimizing the tissue overlap. Tomosynthesis has the potential to improve screening mammography outcomes by increasing cancer detection rates, decreasing false negative rates and false positive rates. This trial will help determine if tomosynthesis is useful in a screening setting.

Detailed Description

We will evaluate the effect of tomosynthesis mammography outcomes in a screening setting. We will collect data on interpretation time, recall rates, cancer detection rates, and interval cancer rates in dense breasts(≥ 50% glandular density). If the interpretation time is less than 4X a routine read, and the recall rates have dropped \< 30% of initial values, we will then conduct a study with larger numbers to better evaluate cancer detection rates and interval cancer rates.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
500
Inclusion Criteria
  • Females 40-69 years of age attending Screen Test Kingsway referred for a screening mammogram as defined by Canadian Cancer Society guidelines.
  • Prior mammogram report indicating ≥ 25% breast density.
Exclusion Criteria
  • Prior mammogram report indicating <25% breast density.
  • Breast implants
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
B: Routine Mammogram + tomosynthesisTomosynthesisRoutine Mammogram and tomosynthesis
A: routine 2D mammogram2D MammogramSubject receives regular 2D mammogram.
Primary Outcome Measures
NameTimeMethod
Interpretation Time of ScanWithin 1 month of receiving scan
Secondary Outcome Measures
NameTimeMethod
Discomfort ScaleImmediately after the subject receives scan
Recall Rates6 month intervals for 2 years after initial scan

Trial Locations

Locations (1)

Alberta Screen Test

🇨🇦

Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath